Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NBI-827104
NBI-827104
Neurocrine's $50M bet on Idorsia drug flames out in second PhII
Endpoints
Wed, 12/7/22 - 09:58 am
Neurocrine
Idorsia
clinical trials
NBI-827104
epileptic encephalopathy
‘A negative trial, not a failed trial’: Neurocrine axes in-licensed tremor program on phase 2 data
Fierce Biotech
Fri, 08/5/22 - 10:44 am
Neurocrine Biosciences
NBI-827104
clinical trials
essential tremor